Lineage Cell Therapeutics, Inc.

LCTXNYSE· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$14.6M

▲ 53.2% YoY

Net Income

-$63.5M

▼ 241.4% YoY

EPS

$-0.28

▼ 211.1% YoY

Cash

$40.8M

▼ 10.9% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.